Garner Asset Management Corp »

Biogen Idec shares owned by Garner Asset Management Corp

Quarter-by-quarter ownership of Biogen Idec (BIIB) shares owned by Garner Asset Management Corp from 13F filings

Historical chart of Garner Asset Management Corp investment in Biogen Idec

Tip: Access up to 7 years of quarterly data

All positions including Biogen Idec held by Garner Asset Management Corp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biogen Idec by Garner Asset Management Corp

Quarter filed Position value Share count Share price at filing
2023-12-31 $5.2k 22 237.86

More positions owned by Garner Asset Management Corp

Berkshire Hathaway Inc Del Cl B New (BRK.B)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Diversified Healthcare Tr Com Shs Ben Int (DHC)
Rmr Group Cl A (RMR)
Brunswick Corporation (BC)
Verizon Communications (VZ)
Amazon (AMZN)
Farmland Partners (FPI)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl C (GOOG)
Costco Wholesale Corporation (COST)
International Paper Company (IP)
Kayne Anderson MLP Investment (KYN)
AutoNation (AN)

View all positions for Garner Asset Management Corp

Top funds holding Biogen Idec

Vanguard Group
PRIMECAP Management Company
BlackRock
Wellington Management Company
T. Rowe Price Investment Management
Jpmorgan Chase & Co
Geode Capital Management
Van Eck Associates Corp.
Morgan Stanley
T. Rowe Price Associates
ClearBridge Advisors
Legal & General Group
Northern Trust
Bank of New York Mellon
Dimensional Fund Advisors

View all funds holding Biogen Idec